MARKETSSTORY 707· JULY 8, 2026

60 Degrees Pharmaceuticals Locks In Rights to Castanospermine for Tick-Borne Disease Research

An exclusive option agreement gives one company the right to negotiate a full license for a technology before any competing party can step in. That is the structure 60 Degrees Pharmaceutica

NDNewsDialy Desk2 MIN READ

SOURCE

globenewswire.com

← PREVIOUS STORY 706Albany contractors who win every job may be undercutting themselves, expert says NEXT STORY 708 →Verdantas acquires American Engineering & Environmental Consultants to deepen AI-driven environmental work

Keep reading

More from the desk.

171MARKETS

Three Temasek India bets each jump more than 30% after listings this week

A contrarian bet is a position placed against the prevailing market view on an asset, held until that view shifts. Singapore's state investor Temasek made those calls on three companies in India. This week, each of them jumped more than…

markets1 MIN

200MARKETS

Bridgewater trims Amazon as it adds to Shell and PG&E

Big money shifted its holdings last quarter, tilting away from technology and toward energy. Holdings, meaning the shares a fund owns at the end of a reporting period, grew for Shell and PG&E at Bridgewater Associates during the second…

markets1 MIN

209MARKETS

Pershing Square narrows its book to three names: Uber, Brookfield, and Microsoft

Concentration, in portfolio management, means putting most of a fund's capital into a small number of positions rather than spreading it across many names. Pershing Square has organized its

markets1 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk